Publikationen in Zusammenarbeit mit Forschern von Eli Lilly and Company (1)

2018

  1. Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study

    The Lancet, Vol. 391, Núm. 10136, pp. 2213-2224